Efficacy and safety of sunitinib alternate day regimen in patients with metastatic renal cell carcinoma in Japan: Comparison with standard 4/2 schedule

Asia-Pacific Journal of Clinical Oncology, EarlyView.

Source: Asia-Pacific Journal of Clinical Oncology - January 31, 2018 Category: Cancer & Oncology Source Type: research